17 days ago
BMY
AnalystsDavid AmsellemDavid Amsellem's Stock Forecasts
AnalystsDavid Amsellem
Analyst Ranking
Top 4%
#199 out of 5530 analysts
Average Return
+19.4%
Win Rate
64%105 out of 163
Risk vs Reward
Poor
Good
David Amsellem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Indivior Pharmaceuticals IncINDV | +224.06% | $9.89 | $32.05 | 2025-03-06 - 2026-03-05 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +222.28% | $2.02 | $6.51 | 2023-05-08 - 2024-05-07 | Strong Buy |
Indivior Pharmaceuticals IncINDV | +218.77% | $7.46 | $23.78 | 2024-10-11 - 2025-10-10 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +189.77% | $31.56 | $91.45 | 2020-04-14 - 2021-04-14 | Strong Buy |
Indivior Pharmaceuticals IncINDV | +179.22% | $9.00 | $25.13 | 2024-10-25 - 2025-10-24 | Strong Buy |
David Amsellem Analyst Color
Get additional color on David Amsellem's coverage of popular stocks
a month ago
ABBV
2 months ago
JAZZ
2 months ago
NBIX
2 months ago
CORT
2 months ago
TEVA
2 months ago
DFTX
4 months ago
JAZZ
5 months ago
ABBV
5 months ago
NBIX
5 months ago
CORT
5 months ago
TEVA
6 months ago
JAZZ
7 months ago
TEVA
8 months ago
ABBV
9 months ago
AXSM
9 months ago
TEVA
10 months ago
JAZZ
a year ago
AQST
a year ago
ABBV
a year ago
INDV
a year ago
AMRX
a year ago
NBIX
a year ago
SUPN
a year ago
NBIX
David Amsellem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $258.00 | +43.93% | Reiterates | 15 days ago |
Viatris IncVTRS | 9 | Hold | $13.00 | -26.14% | Maintains | 17 days ago |
Bristol Myers Squibb CoBMY | 4 | Strong Buy | $82.00 | +34.10% | Reiterates | 17 days ago |
Biogen IncBIIB | 7 | Strong Buy | $245.00 | +11.42% | Reiterates | a month ago |
Amgen IncAMGN | 9 | Strong Buy | $457.00 | +13.39% | Maintains | a month ago |
Abbvie IncABBV | 8 | Strong Buy | $303.00 | +15.29% | Maintains | a month ago |
Definium Therapeutics IncDFTX | 4 | Strong Buy | $75.00 | +100.53% | Reiterates | 2 months ago |
Collegium Pharmaceutical IncCOLL | 8 | Hold | $43.00 | +95.28% | Reiterates | 2 months ago |
Amphastar Pharmaceuticals IncAMPH | 10 | Hold | $20.00 | -21.35% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 13 | Strong Buy | $310.00 | +31.54% | Maintains | 2 months ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $210.00 | +46.67% | Maintains | 2 months ago |
Corcept Therapeutics IncCORT | 10 | Strong Buy | $165.00 | +41.96% | Reiterates | 2 months ago |
Alkermes PLCALKS | 10 | Strong Buy | $65.00 | +55.69% | Reiterates | 2 months ago |
Teva Pharmaceutical Industries LtdTEVA | 11 | Strong Buy | $44.00 | +11.31% | Maintains | 2 months ago |
Organon & CoOGN | 7 | Hold | $14.00 | +2.04% | Upgrades | 5 months ago |
Pelthos Therapeutics IncPTHS | 1 | Strong Buy | $48.00 | +133.01% | Initiates Coverage On | 7 months ago |
Fennec Pharmaceuticals IncFENC | 1 | Strong Buy | $18.00 | +76.47% | Initiates Coverage On | 9 months ago |
Esperion Therapeutics IncESPR | 1 | Strong Buy | $9.00 | +183.02% | Initiates Coverage On | 10 months ago |
Aquestive Therapeutics IncAQST | 2 | Strong Buy | $8.00 | +75.82% | Maintains | a year ago |
Xeris Biopharma Holdings IncXERS | 6 | Hold | $8.00 | -11.89% | Maintains | a year ago |
Indivior Pharmaceuticals IncINDV | 6 | Strong Buy | $41.00 | +14.81% | Reiterates | a year ago |
Amneal Pharmaceuticals IncAMRX | 5 | Strong Buy | $13.00 | -35.96% | Reiterates | a year ago |
Supernus Pharmaceuticals IncSUPN | 12 | Strong Buy | $65.00 | +53.37% | Upgrades | a year ago |
Sage Therapeutics IncSAGE | 2 | Hold | $8.50 | N/A | Downgrades | a year ago |
Optinose IncOPTN | 3 | Hold | $9.00 | N/A | Downgrades | 2 years ago |
Intra Cellular Therapies IncITCI | 1 | Hold | $132.00 | N/A | Downgrades | 2 years ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Strong Buy | $13.00 | N/A | Maintains | 2 years ago |
Ani Pharmaceuticals IncANIP | 1 | Strong Buy | $68.00 | N/A | Initiates Coverage On | 2 years ago |
Revance Therapeutics IncRVNC | 7 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Bausch Health Companies IncBHC | 4 | Strong Sell | $3.00 | N/A | Downgrades | 2 years ago |
Pacira Biosciences IncPCRX | 7 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Ironwood Pharmaceuticals IncIRWD | 3 | Strong Buy | $21.00 | N/A | Maintains | 3 years ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $45.00 | N/A | Downgrades | 3 years ago |
Tvardi Therapeutics IncTVRD | 3 | Hold | $12.00 | N/A | Downgrades | 3 years ago |
Harmony Biosciences Holdings IncHRMY | 3 | Strong Buy | $42.00 | N/A | Maintains | 3 years ago |
Eagle Pharmaceuticals IncEGRX | 2 | Strong Sell | $17.00 | N/A | Downgrades | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $285.00 | N/A | Initiates Coverage On | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Strong Buy | $110.00 | N/A | Maintains | 4 years ago |
Antares Pharma IncATRS | 1 | Hold | $5.60 | N/A | Downgrades | 4 years ago |
Endo International PLCENDPQ | 3 | Hold | $3.00 | N/A | Maintains | 5 years ago |
Biodelivery Sciences International IncBDSI | 1 | Hold | $5.60 | N/A | Downgrades | 5 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | $8.00 | N/A | Downgrades | 5 years ago |
Evofem Biosciences IncEVFM | 1 | Strong Buy | $165.00 | N/A | Initiates Coverage On | 6 years ago |
Impax Laboratories IncIPXL | 1 | Hold | N/A | N/A | Upgrades | 9 years ago |
Societal Cdmo IncSCTL | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.